553,742 Shares in Pediatrix Medical Group, Inc. $MD Acquired by Nuveen LLC

Nuveen LLC purchased a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 553,742 shares of the company’s stock, valued at approximately $8,024,000. Nuveen LLC owned about 0.64% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. California State Teachers Retirement System increased its position in Pediatrix Medical Group by 0.9% during the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company’s stock worth $1,054,000 after purchasing an additional 752 shares during the last quarter. SummerHaven Investment Management LLC increased its position in Pediatrix Medical Group by 0.9% during the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company’s stock worth $1,628,000 after purchasing an additional 1,028 shares during the last quarter. Natixis Advisors LLC increased its position in Pediatrix Medical Group by 8.1% during the first quarter. Natixis Advisors LLC now owns 19,156 shares of the company’s stock worth $278,000 after purchasing an additional 1,435 shares during the last quarter. GAMMA Investing LLC increased its position in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after purchasing an additional 1,765 shares during the last quarter. Finally, New York State Teachers Retirement System increased its position in Pediatrix Medical Group by 1.9% during the first quarter. New York State Teachers Retirement System now owns 133,313 shares of the company’s stock worth $1,932,000 after purchasing an additional 2,527 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on MD. Zacks Research raised shares of Pediatrix Medical Group to a “strong-buy” rating in a research report on Monday, August 11th. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Finally, Macquarie boosted their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Pediatrix Medical Group currently has an average rating of “Moderate Buy” and a consensus target price of $16.75.

Pediatrix Medical Group Price Performance

MD opened at $16.9730 on Friday. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a 52-week low of $10.06 and a 52-week high of $17.67. The company has a 50 day moving average of $13.76 and a two-hundred day moving average of $13.93. The company has a market cap of $1.48 billion, a P/E ratio of 13.16 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. During the same period in the previous year, the firm earned $0.34 earnings per share. Pediatrix Medical Group’s revenue for the quarter was down 7.1% on a year-over-year basis. On average, analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.